These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21204733)

  • 1. Targeting liver X receptors in human health: deadlock or promising trail?
    Viennois E; Pommier AJ; Mouzat K; Oumeddour A; El Hajjaji FZ; Dufour J; Caira F; Volle DH; Baron S; Lobaccaro JM
    Expert Opin Ther Targets; 2011 Feb; 15(2):219-32. PubMed ID: 21204733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective liver X receptor modulators (SLiMs): what use in human health?
    Viennois E; Mouzat K; Dufour J; Morel L; Lobaccaro JM; Baron S
    Mol Cell Endocrinol; 2012 Apr; 351(2):129-41. PubMed ID: 21907760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptors as potential therapeutic targets in atherosclerosis.
    Zhu Y; Li Y
    Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxysterol receptors and their therapeutic applications in cancer conditions.
    De Boussac H; Alioui A; Viennois E; Dufour J; Trousson A; Vega A; Guy L; Volle DH; Lobaccaro JM; Baron S
    Expert Opin Ther Targets; 2013 Sep; 17(9):1029-38. PubMed ID: 23875732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The liver X receptors.
    Lala DS
    Curr Opin Investig Drugs; 2005 Sep; 6(9):934-43. PubMed ID: 16187693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
    Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
    Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor: a potential target in the treatment of atherosclerosis.
    Savla SR; Prabhavalkar KS; Bhatt LK
    Expert Opin Ther Targets; 2022 Jul; 26(7):645-658. PubMed ID: 36003057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the liver X receptors in skin physiology: Putative pharmacological targets in human diseases.
    Ouedraogo ZG; Fouache A; Trousson A; Baron S; Lobaccaro JA
    Chem Phys Lipids; 2017 Oct; 207(Pt B):59-68. PubMed ID: 28259649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological role of liver X receptors.
    Baranowski M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural modulators of liver X receptors.
    Huang C
    J Integr Med; 2014 Mar; 12(2):76-85. PubMed ID: 24666673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.
    Berrodin TJ; Shen Q; Quinet EM; Yudt MR; Freedman LP; Nagpal S
    Mol Pharmacol; 2010 Dec; 78(6):1046-58. PubMed ID: 20837678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).
    Li X; Yeh V; Molteni V
    Expert Opin Ther Pat; 2010 Apr; 20(4):535-62. PubMed ID: 20302451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases.
    Faulds MH; Zhao C; Dahlman-Wright K
    Curr Opin Pharmacol; 2010 Dec; 10(6):692-7. PubMed ID: 20829110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medicinal chemistry of liver X receptor (LXR) modulators.
    Tice CM; Noto PB; Fan KY; Zhuang L; Lala DS; Singh SB
    J Med Chem; 2014 Sep; 57(17):7182-205. PubMed ID: 24832115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors.
    Kang J; Rivest S
    Endocr Rev; 2012 Oct; 33(5):715-46. PubMed ID: 22766509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.
    Xiao L; Xie X; Zhai Y
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer.
    Bovenga F; Sabbà C; Moschetta A
    Cell Metab; 2015 Apr; 21(4):517-26. PubMed ID: 25863245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.
    Jakobsson T; Treuter E; Gustafsson JÅ; Steffensen KR
    Trends Pharmacol Sci; 2012 Jul; 33(7):394-404. PubMed ID: 22541735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging roles of liver X receptors and their ligands in cancer.
    Lin CY; Vedin LL; Steffensen KR
    Expert Opin Ther Targets; 2016; 20(1):61-71. PubMed ID: 26788589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (RORγ)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligand.
    Nishiyama Y; Nakamura M; Misawa T; Nakagomi M; Makishima M; Ishikawa M; Hashimoto Y
    Bioorg Med Chem; 2014 May; 22(9):2799-808. PubMed ID: 24702856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.